Jordi Esteve Selected Research

Jordi Esteve Research Topics

Disease

58	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 02/2003
54	Leukemia 10/2022 - 04/2003
16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2003
10	Neoplasms (Cancer) 03/2022 - 07/2004
9	Acute Promyelocytic Leukemia 05/2020 - 04/2008
8	Infections 06/2021 - 07/2002
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 03/2002
7	Philadelphia Chromosome 01/2022 - 01/2010
7	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014 - 04/2003
5	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 10/2015
5	Residual Neoplasm 11/2019 - 03/2002
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 01/2018
4	Multiple Myeloma 12/2006 - 05/2004
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2021 - 07/2005
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 09/2011
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 08/2011
3	Left Ventricular Dysfunction 12/2013 - 08/2011
2	Hematologic Diseases (Blood Diseases) 06/2021 - 01/2017
2	Neutropenia 11/2020 - 01/2020
2	Febrile Neutropenia 01/2020 - 09/2014
2	monosomy Chromosome 7 01/2020 - 01/2018
2	Monosomy 01/2020 - 01/2018
2	Thrombocytopenia (Thrombopenia) 01/2020 - 11/2014
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2016 - 09/2014
2	Fever (Fevers) 09/2014 - 04/2008
2	Lymphoma (Lymphomas) 05/2013 - 07/2005
2	HIV Infections (HIV Infection) 07/2008 - 04/2003
2	Hemorrhage 04/2008 - 02/2008
2	Plasmacytoma 07/2004 - 05/2004
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2003 - 07/2002
1	Thrombotic Thrombocytopenic Purpura 02/2021
1	Disseminated Intravascular Coagulation 01/2021
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Obesity 03/2020

Drug/Important Bio-Agent (IBA)

10	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021 - 07/2004
8	AnthracyclinesIBA 01/2019 - 07/2004
7	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 04/2008
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2018 - 02/2003
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2015
4	Rituximab (Mabthera)FDA Link 02/2021 - 07/2008
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2018 - 02/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2021
3	fludarabineIBA 01/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2016 - 01/2004
3	Enalapril FDA LinkGeneric 12/2013 - 08/2011
3	Carvedilol (Coreg)FDA LinkGeneric 12/2013 - 08/2011
3	Thalidomide (Thalomid)FDA Link 12/2006 - 05/2004
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2020
2	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2010
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 10/2008
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2018
2	Retinoic Acid Receptor alphaIBA 10/2021 - 05/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2021 - 09/2014
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 09/2013
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 01/2019
2	plerixafor FDA Link 05/2018 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015 - 11/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 04/2007 - 09/2005
1	siremadlinIBA 03/2022
1	Melphalan (Alkeran)FDA LinkGeneric 01/2022
1	ponatinibIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	alvocidib (flavopiridol)IBA 10/2021
1	Core Binding Factor Alpha 2 SubunitIBA 10/2021
1	Phosphotransferases (Kinase)IBA 08/2021
1	BI 6727IBA 08/2021
1	Viral RNAIBA 06/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2021
1	Thrombospondin 1IBA 02/2021
1	von Willebrand FactorIBA 02/2021
1	caplacizumabIBA 02/2021
1	Metalloproteases (Metalloproteinases)IBA 02/2021
1	SteroidsIBA 02/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2021
1	AutoantibodiesIBA 02/2021
1	DisintegrinsIBA 02/2021
1	ArsenicIBA 01/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	Histamine Receptors (Histamine Receptor)IBA 11/2020
1	RG7388IBA 05/2020

Therapy/Procedure

36	Transplantation 10/2022 - 07/2002
28	Stem Cell Transplantation 01/2022 - 03/2002
26	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
26	Therapeutics 01/2022 - 04/2003
25	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2004
11	Cell Transplantation 10/2022 - 01/2016
4	Consolidation Chemotherapy 01/2022 - 02/2003
3	Immunotherapy 11/2020 - 07/2008
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
2	Plasma Exchange 02/2021 - 11/2014
2	Homologous Transplantation 01/2021 - 01/2018
2	Aftercare (After-Treatment) 01/2020 - 10/2008
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2017 - 07/2002
2	Induction Chemotherapy 09/2014 - 01/2012